Treffer: Alternating magnetic fields enhance anti-biofilm activity across pathogen and antibiotic space.
PLoS One. 2017 Jan 03;12(1):e0169068. (PMID: 28046049)
J Rheumatol. 2019 Sep;46(9):1134-1140. (PMID: 30988126)
Arthroplasty. 2022 Sep 1;4(1):31. (PMID: 36045436)
J Bone Jt Infect. 2019 Sep 17;4(4):198-202. (PMID: 31555507)
J Arthroplasty. 2021 May;36(5):1484-1489.e3. (PMID: 33422392)
Int J Hyperthermia. 2022;39(1):713-724. (PMID: 35634916)
J Int Med Res. 2021 Mar;49(3):3000605211002784. (PMID: 33787371)
Clin Orthop Relat Res. 2003 Aug;(413):175-82. (PMID: 12897608)
JB JS Open Access. 2018 Aug 15;3(3):e0007. (PMID: 30533590)
Arthroplast Today. 2017 Mar 14;3(2):67-69. (PMID: 28695176)
NPJ Biofilms Microbiomes. 2021 Aug 12;7(1):68. (PMID: 34385452)
Clin Orthop Relat Res. 2008 Jul;466(7):1710-5. (PMID: 18421542)
Open Orthop J. 2016 Nov 30;10:615-632. (PMID: 28503214)
Biofouling. 2017 Nov;33(10):855-866. (PMID: 29039211)
Int J Hyperthermia. 2022;39(1):81-96. (PMID: 34949138)
Antibiotics (Basel). 2021 Jun 19;10(6):. (PMID: 34205424)
Materials (Basel). 2019 Feb 05;12(3):. (PMID: 30764574)
Biofouling. 2023 May-Jul;39(5):516-526. (PMID: 37483168)
J Infect. 2024 Nov;89(5):106271. (PMID: 39278276)
J Clin Med. 2019 May 13;8(5):. (PMID: 31086080)
F1000Res. 2024 Oct 22;13:443. (PMID: 39866728)
Sci Rep. 2017 Aug 8;7(1):7520. (PMID: 28790407)
Antibiotics (Basel). 2020 Dec 23;10(1):. (PMID: 33374551)
Sci Rep. 2023 Dec 17;13(1):22456. (PMID: 38105253)
ISQ9I6J12J (Linezolid)
5E8K9I0O4U (Ciprofloxacin)
Weitere Informationen
Prosthetic joint infection (PJI) is a severe complication of total joint arthroplasty, contributing to significant patient morbidity and increased healthcare costs. The formation of biofilm on the implant hinders effective therapy, and removal of the prosthesis is frequently required. High frequency alternating magnetic fields (AMF) have emerged as a promising noninvasive approach to disrupt biofilm and have the potential to augment antibiotic activity. This study evaluated the impact of AMF on antibiotic activity in biofilms of clinically relevant PJI pathogens. Across multiple bacterial strains, AMF significantly improved biofilm eradication when administered with antibiotics, achieving greater reductions in bacterial burden compared to antibiotic monotherapy. There was an average reduction of 5.72-log across Gram-positive pathogens when treated with AMF and linezolid, and an average 5.11-log reduction of Gram-negative biofilm when treated with AMF and ciprofloxacin. The bactericidal response was independent of metal composition, suggesting broad applicability to different conductive prosthetic materials. Additionally, biofilm reduction was time and temperature-dependent, with peak efficacy observed at 80 °C. These findings support AMF as a potential adjunctive therapy for PJI, warranting further investigation in clinical settings to optimize treatment strategies and improve patient outcomes.
(© 2025. The Author(s).)
Declarations. Competing interests: D.E.G. and R.C. are inventors of the AMF device and are employees and/or consultants for Solenic Medical. D.E.G. and R.C. own stock in Solenic Medical. B.P. and V.S. are employees of Solenic Medical. Remaining authors do not have any competing interests to declare.